Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 11 | 2019 | 249 | 2.450 |
Why?
|
| Firearms | 2 | 2019 | 7 | 1.410 |
Why?
|
| Wounds, Gunshot | 2 | 2019 | 34 | 1.350 |
Why?
|
| Venous Thromboembolism | 3 | 2017 | 25 | 1.280 |
Why?
|
| Child | 25 | 2019 | 2209 | 1.200 |
Why?
|
| Child Abuse | 2 | 2019 | 26 | 1.150 |
Why?
|
| Craniocerebral Trauma | 3 | 2015 | 56 | 0.990 |
Why?
|
| Societies, Medical | 3 | 2019 | 149 | 0.970 |
Why?
|
| Mental Health Services | 2 | 2019 | 24 | 0.860 |
Why?
|
| Schools | 2 | 2019 | 64 | 0.830 |
Why?
|
| Accidents, Traffic | 6 | 2018 | 184 | 0.740 |
Why?
|
| Child, Preschool | 15 | 2019 | 1164 | 0.730 |
Why?
|
| Crime Victims | 1 | 2019 | 8 | 0.700 |
Why?
|
| Mandatory Reporting | 1 | 2019 | 7 | 0.700 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 43 | 0.680 |
Why?
|
| Intubation, Intratracheal | 1 | 2019 | 70 | 0.650 |
Why?
|
| Referral and Consultation | 1 | 2019 | 113 | 0.640 |
Why?
|
| Infant | 14 | 2019 | 967 | 0.630 |
Why?
|
| Hemorrhage | 2 | 2015 | 90 | 0.610 |
Why?
|
| Adolescent | 17 | 2019 | 3248 | 0.610 |
Why?
|
| Trauma Centers | 4 | 2019 | 84 | 0.580 |
Why?
|
| Triage | 4 | 2018 | 65 | 0.570 |
Why?
|
| Consensus | 1 | 2016 | 68 | 0.560 |
Why?
|
| Humans | 35 | 2019 | 28998 | 0.550 |
Why?
|
| United States | 9 | 2019 | 3604 | 0.530 |
Why?
|
| Endosonography | 2 | 2016 | 56 | 0.520 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 32 | 0.520 |
Why?
|
| Algorithms | 5 | 2019 | 461 | 0.520 |
Why?
|
| Professional-Family Relations | 1 | 2015 | 15 | 0.520 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 92 | 0.520 |
Why?
|
| Hypotension | 1 | 2015 | 47 | 0.510 |
Why?
|
| Empathy | 1 | 2015 | 17 | 0.510 |
Why?
|
| Informed Consent | 1 | 2015 | 51 | 0.500 |
Why?
|
| Fundoplication | 2 | 2012 | 8 | 0.490 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 373 | 0.490 |
Why?
|
| Vena Cava, Inferior | 1 | 2014 | 31 | 0.480 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 48 | 0.480 |
Why?
|
| Decision Making | 2 | 2018 | 180 | 0.480 |
Why?
|
| Parents | 1 | 2015 | 117 | 0.470 |
Why?
|
| Infant, Newborn | 11 | 2018 | 595 | 0.470 |
Why?
|
| Postoperative Complications | 2 | 2016 | 670 | 0.470 |
Why?
|
| Shock | 1 | 2013 | 28 | 0.460 |
Why?
|
| Gastroplasty | 1 | 2012 | 11 | 0.420 |
Why?
|
| Vomiting | 1 | 2012 | 24 | 0.420 |
Why?
|
| Pediatrics | 3 | 2019 | 132 | 0.420 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 25 | 0.420 |
Why?
|
| Cholelithiasis | 1 | 2011 | 10 | 0.400 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2011 | 12 | 0.400 |
Why?
|
| Abbreviated Injury Scale | 5 | 2018 | 57 | 0.390 |
Why?
|
| Thoracotomy | 2 | 2008 | 22 | 0.370 |
Why?
|
| Neuroblastoma | 2 | 2006 | 32 | 0.360 |
Why?
|
| Male | 17 | 2019 | 17767 | 0.340 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2005 | 20 | 0.340 |
Why?
|
| Female | 15 | 2019 | 18112 | 0.330 |
Why?
|
| Hemangioma, Capillary | 1 | 2008 | 3 | 0.330 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2008 | 8 | 0.320 |
Why?
|
| Laparoscopy | 5 | 2015 | 169 | 0.310 |
Why?
|
| Mediastinal Neoplasms | 1 | 2006 | 13 | 0.290 |
Why?
|
| Retrospective Studies | 9 | 2016 | 3100 | 0.290 |
Why?
|
| Thoracoscopy | 1 | 2006 | 9 | 0.290 |
Why?
|
| Injury Severity Score | 3 | 2017 | 115 | 0.280 |
Why?
|
| Short Bowel Syndrome | 1 | 2005 | 8 | 0.270 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2005 | 23 | 0.260 |
Why?
|
| Age Factors | 5 | 2019 | 1105 | 0.260 |
Why?
|
| Child Development | 2 | 2015 | 35 | 0.260 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 2105 | 0.250 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 383 | 0.240 |
Why?
|
| Risk Assessment | 6 | 2017 | 1300 | 0.240 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 18 | 0.220 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 45 | 0.210 |
Why?
|
| Oncology Service, Hospital | 1 | 2002 | 4 | 0.210 |
Why?
|
| Antigens, Neoplasm | 1 | 2002 | 44 | 0.210 |
Why?
|
| Medical Oncology | 2 | 2002 | 70 | 0.210 |
Why?
|
| Abdominal Injuries | 2 | 2019 | 33 | 0.210 |
Why?
|
| Pylorus | 2 | 2015 | 5 | 0.210 |
Why?
|
| Guideline Adherence | 1 | 2002 | 110 | 0.200 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 208 | 0.180 |
Why?
|
| Homicide | 1 | 2019 | 2 | 0.180 |
Why?
|
| First Aid | 1 | 2019 | 6 | 0.180 |
Why?
|
| Suicide | 1 | 2019 | 17 | 0.180 |
Why?
|
| Mass Casualty Incidents | 1 | 2019 | 18 | 0.180 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 724 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 301 | 0.170 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 24 | 0.170 |
Why?
|
| Public Policy | 1 | 2019 | 34 | 0.170 |
Why?
|
| Physician's Role | 1 | 2019 | 38 | 0.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 43 | 0.170 |
Why?
|
| Counseling | 1 | 2019 | 85 | 0.170 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 53 | 0.170 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 45 | 0.170 |
Why?
|
| Motor Vehicles | 1 | 2018 | 22 | 0.160 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2019 | 90 | 0.160 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 51 | 0.160 |
Why?
|
| Neoplasms | 2 | 2016 | 608 | 0.160 |
Why?
|
| Patient Transfer | 1 | 2017 | 34 | 0.150 |
Why?
|
| Chemoprevention | 1 | 2017 | 9 | 0.150 |
Why?
|
| Premedication | 1 | 2017 | 10 | 0.150 |
Why?
|
| Disabled Children | 1 | 2017 | 18 | 0.150 |
Why?
|
| Cecostomy | 1 | 2016 | 1 | 0.150 |
Why?
|
| Enema | 1 | 2016 | 6 | 0.150 |
Why?
|
| Constipation | 1 | 2016 | 12 | 0.150 |
Why?
|
| Digestive System Diseases | 1 | 2016 | 5 | 0.150 |
Why?
|
| Fecal Incontinence | 1 | 2016 | 21 | 0.140 |
Why?
|
| Age Distribution | 2 | 2015 | 197 | 0.140 |
Why?
|
| Cryopreservation | 1 | 2016 | 42 | 0.140 |
Why?
|
| Pyloric Stenosis | 1 | 2015 | 2 | 0.140 |
Why?
|
| Spermatogenesis | 1 | 2016 | 45 | 0.140 |
Why?
|
| Testis | 1 | 2016 | 60 | 0.130 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 27 | 0.130 |
Why?
|
| Ultrasonography | 2 | 2015 | 345 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 871 | 0.130 |
Why?
|
| Incidence | 2 | 2015 | 1105 | 0.120 |
Why?
|
| Age of Onset | 2 | 2011 | 95 | 0.120 |
Why?
|
| Registries | 1 | 2015 | 278 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 53 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 519 | 0.120 |
Why?
|
| Heparin | 1 | 2014 | 75 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2014 | 120 | 0.110 |
Why?
|
| Radiography | 1 | 2014 | 353 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 523 | 0.110 |
Why?
|
| Risk Factors | 2 | 2017 | 3509 | 0.110 |
Why?
|
| Length of Stay | 2 | 2019 | 291 | 0.100 |
Why?
|
| Education, Medical, Continuing | 2 | 2002 | 45 | 0.100 |
Why?
|
| Dogs | 1 | 2012 | 117 | 0.100 |
Why?
|
| Technetium Tc 99m Lidofenin | 1 | 2011 | 3 | 0.100 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cholagogues and Choleretics | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cholangiography | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2011 | 7 | 0.100 |
Why?
|
| False Negative Reactions | 1 | 2011 | 21 | 0.100 |
Why?
|
| Ceftriaxone | 1 | 2011 | 11 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 29 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2011 | 18 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 35 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2017 | 331 | 0.100 |
Why?
|
| Prognosis | 2 | 2006 | 1362 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 97 | 0.090 |
Why?
|
| Anticipation, Genetic | 1 | 2009 | 1 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 2009 | 21 | 0.090 |
Why?
|
| Comorbidity | 1 | 2011 | 539 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 87 | 0.080 |
Why?
|
| Pneumonectomy | 1 | 2008 | 6 | 0.080 |
Why?
|
| Neoplasm Staging | 2 | 2006 | 436 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2008 | 20 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 89 | 0.080 |
Why?
|
| Hepatic Artery | 1 | 2006 | 10 | 0.070 |
Why?
|
| Urinary Retention | 1 | 2006 | 6 | 0.070 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2006 | 7 | 0.070 |
Why?
|
| Thoracic Injuries | 2 | 2018 | 50 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2006 | 11 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 281 | 0.070 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2005 | 2 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3094 | 0.070 |
Why?
|
| Gastrostomy | 1 | 2005 | 17 | 0.070 |
Why?
|
| Oregon | 2 | 2002 | 7 | 0.070 |
Why?
|
| Drainage | 1 | 2005 | 49 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 863 | 0.060 |
Why?
|
| Receptors, OX40 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Argon | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hemostasis, Surgical | 1 | 2002 | 13 | 0.050 |
Why?
|
| Laser Coagulation | 1 | 2002 | 12 | 0.050 |
Why?
|
| Albumins | 1 | 2002 | 38 | 0.050 |
Why?
|
| Education, Nursing, Continuing | 1 | 2002 | 2 | 0.050 |
Why?
|
| Adult | 4 | 2015 | 8391 | 0.050 |
Why?
|
| Animals | 2 | 2012 | 7296 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2002 | 61 | 0.050 |
Why?
|
| Physical Examination | 1 | 2002 | 82 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2002 | 176 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2002 | 440 | 0.050 |
Why?
|
| Reoperation | 2 | 2015 | 203 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2002 | 307 | 0.040 |
Why?
|
| Liver | 1 | 2002 | 464 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 79 | 0.040 |
Why?
|
| Spinal Injuries | 1 | 2018 | 20 | 0.040 |
Why?
|
| Probability | 1 | 2018 | 150 | 0.040 |
Why?
|
| Child, Hospitalized | 1 | 2017 | 8 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 1997 | 0.040 |
Why?
|
| Manometry | 1 | 2016 | 19 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2002 | 2010 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2016 | 16 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2016 | 26 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2015 | 9 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 666 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 124 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 235 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 3712 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 725 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2015 | 149 | 0.030 |
Why?
|
| Bleomycin | 1 | 2009 | 10 | 0.020 |
Why?
|
| Menopause, Premature | 1 | 2009 | 8 | 0.020 |
Why?
|
| Etoposide | 1 | 2009 | 30 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2009 | 13 | 0.020 |
Why?
|
| Hypercalcemia | 1 | 2009 | 8 | 0.020 |
Why?
|
| Remission Induction | 1 | 2009 | 78 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2009 | 40 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2009 | 68 | 0.020 |
Why?
|
| Pedigree | 1 | 2009 | 133 | 0.020 |
Why?
|
| Cisplatin | 1 | 2009 | 69 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 78 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 163 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2009 | 147 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2009 | 86 | 0.020 |
Why?
|
| Aged | 1 | 2002 | 9461 | 0.020 |
Why?
|
| Middle Aged | 1 | 2002 | 10805 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 401 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 8 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2006 | 13 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2006 | 22 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2005 | 28 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2005 | 12 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 2005 | 30 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 493 | 0.020 |
Why?
|
| Breast Self-Examination | 1 | 2002 | 1 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2002 | 45 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 2002 | 38 | 0.010 |
Why?
|
| Swine | 1 | 2002 | 201 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 212 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 160 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2002 | 66 | 0.010 |
Why?
|
| Program Development | 1 | 2002 | 85 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2002 | 175 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 531 | 0.010 |
Why?
|
| Curriculum | 1 | 2002 | 196 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2002 | 178 | 0.010 |
Why?
|
| Mass Screening | 1 | 2002 | 223 | 0.010 |
Why?
|